Biochemical network-based drug-target prediction.
暂无分享,去创建一个
[1] Clifford Dobell,et al. The Life-history and Chromosome Cycle of Aggregata eberthi [Protozoa: Sporozoa: Coccidia] , 1925, Parasitology.
[2] Paul A. Bates,et al. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system , 2008, Proceedings of the National Academy of Sciences.
[3] Rainer Breitling,et al. Metabolomic systems biology of trypanosomes , 2010, Parasitology.
[4] D. Lauffenburger,et al. Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data , 2009, Molecular systems biology.
[5] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[6] Yukiko Matsuoka,et al. Using process diagrams for the graphical representation of biological networks , 2005, Nature Biotechnology.
[7] Masamitsu Iino,et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks , 2005, Nature Genetics.
[8] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[9] John P. Overington,et al. Genomic-scale prioritization of drug targets: the TDR Targets database , 2008, Nature Reviews Drug Discovery.
[10] Lu Huang,et al. Update of TTD: Therapeutic Target Database , 2009, Nucleic Acids Res..
[11] Jens Timmer,et al. Systems-level interactions between insulin–EGF networks amplify mitogenic signaling , 2009, Molecular systems biology.
[12] Igor Goryanin,et al. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] Christian von Mering,et al. STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..
[14] A. Barabasi,et al. Drug—target network , 2007, Nature Biotechnology.
[15] Sven Sahle,et al. A new strategy for assessing sensitivities in biochemical models , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[16] S. Kuhara,et al. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data , 2007, BMC pharmacology.
[17] Olaf Wolkenhauer,et al. Report on EU–USA Workshop: How Systems Biology Can Advance Cancer Research (27 October 2008) , 2009, Molecular oncology.
[18] Hiroaki Kitano,et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..
[19] Nagasuma R. Chandra,et al. Flux balance analysis of biological systems: applications and challenges , 2009, Briefings Bioinform..
[20] R. Solé,et al. The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.
[21] Jaques Reifman,et al. A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis , 2009, BMC Systems Biology.
[22] Holger Fröhlich,et al. Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance , 2009, BMC Systems Biology.
[23] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[24] Steffen Klamt,et al. The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data , 2009, PLoS Comput. Biol..
[25] Jean Clairambault,et al. Circadian timing in cancer treatments. , 2010, Annual review of pharmacology and toxicology.
[26] Paul Brazhnik,et al. Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. , 2009, Biophysical journal.
[27] Edda Klipp,et al. TIde: a software for the systematic scanning of drug targets in kinetic network models , 2009, BMC Bioinformatics.
[28] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[29] Hiroaki Kitano,et al. Structure of Protein Interaction Networks and Their Implications on Drug Design , 2009, PLoS Comput. Biol..
[30] Steven A. Brown,et al. Molecular insights into human daily behavior , 2008, Proceedings of the National Academy of Sciences.
[31] Anton Yuryev,et al. Pathway analysis for drug discovery : computational infrastructure and applications , 2008 .
[32] Matthias Stein,et al. SYCAMORE - a systems biology computational analysis and modeling research environment , 2008, Bioinform..
[33] Xiaomin Luo,et al. PDTD: a web-accessible protein database for drug target identification , 2008, BMC Bioinformatics.
[34] Martin Vingron,et al. A systems biological approach suggests that transcriptional feedback regulation by dual‐specificity phosphatase 6 shapes extracellular signal‐related kinase activity in RAS‐transformed fibroblasts , 2009, The FEBS journal.
[35] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[36] Giovanni Colonna,et al. Modeling of the Bacterial Mechanism of Methicillin-Resistance by a Systems Biology Approach , 2009, PloS one.
[37] J. Mestres,et al. Drug‐Target Networks , 2010, Molecular informatics.
[38] Ueli Schibler,et al. Circadian rhythms: mechanisms and therapeutic implications. , 2007, Annual review of pharmacology and toxicology.
[39] Edda Klipp,et al. Constraint-Based Modeling and Kinetic Analysis of the Smad Dependent TGF-β Signaling Pathway , 2007, PloS one.
[40] Mudita Singhal,et al. COPASI - a COmplex PAthway SImulator , 2006, Bioinform..
[41] Reinhart Heinrich,et al. The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway , 2003, PLoS biology.
[42] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[43] Renate Kania,et al. Storing and Annotating of Kinetic Data , 2007, Silico Biol..
[44] R Nussinov,et al. Towards drugs targeting multiple proteins in a systems biology approach. , 2007, Current topics in medicinal chemistry.
[45] J. Timmer,et al. Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] Damian Szklarczyk,et al. STITCH 2: an interaction network database for small molecules and proteins , 2009, Nucleic Acids Res..
[47] Alexander N. Gorban,et al. Robust simplifications of multiscale biochemical networks , 2008, BMC Systems Biology.
[48] P. Bork,et al. iPath: interactive exploration of biochemical pathways and networks. , 2008, Trends in biochemical sciences.
[49] James Vlasblom,et al. Challenges and Rewards of Interaction Proteomics * , 2009, Molecular & Cellular Proteomics.
[50] Wei Jiang,et al. The analysis of the drug–targets based on the topological properties in the human protein–protein interaction network , 2009, Journal of drug targeting.
[51] V. Grantcharova,et al. Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis , 2009, Science Signaling.